Alzheimer's disease neuropathological changes (A1, B1, C2) (Fig. 1C, left panel) were low level 15, and were accompanied by the presence of marked tau pathology in the anteromedial temporal lobe (Fig. 1C, middle panel). Here, MAPT is linked to Alzheimer disease.